The professor of hematology at University of Lille and chair of LYSA also discussed what the group will be focusing on in 2024.
Franck Morschhauser, MD, PhD
Advertisement
Articles by Franck Morschhauser, MD, PhD
The professor of hematology at University of Lille and chair of LYSA shared updated data from the TRANSCEND-FL trial.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – November 5, 2025
2
Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis
3
What Were the Most Significant Inflection Points or Breakthroughs in Cell and Gene Therapy?
4
Quarter Century Update: The Impact of Artificial Intelligence
5
